Sachpekidis, C.; Hassel, J.C.; Kopp-Schneider, A.; Haberkorn, U.; Dimitrakopoulou-Strauss, A.
Quantitative Dynamic 18F-FDG PET/CT in Survival Prediction of Metastatic Melanoma under PD-1 Inhibitors. Cancers 2021, 13, 1019.
https://doi.org/10.3390/cancers13051019
AMA Style
Sachpekidis C, Hassel JC, Kopp-Schneider A, Haberkorn U, Dimitrakopoulou-Strauss A.
Quantitative Dynamic 18F-FDG PET/CT in Survival Prediction of Metastatic Melanoma under PD-1 Inhibitors. Cancers. 2021; 13(5):1019.
https://doi.org/10.3390/cancers13051019
Chicago/Turabian Style
Sachpekidis, Christos, Jessica C. Hassel, Annette Kopp-Schneider, Uwe Haberkorn, and Antonia Dimitrakopoulou-Strauss.
2021. "Quantitative Dynamic 18F-FDG PET/CT in Survival Prediction of Metastatic Melanoma under PD-1 Inhibitors" Cancers 13, no. 5: 1019.
https://doi.org/10.3390/cancers13051019
APA Style
Sachpekidis, C., Hassel, J. C., Kopp-Schneider, A., Haberkorn, U., & Dimitrakopoulou-Strauss, A.
(2021). Quantitative Dynamic 18F-FDG PET/CT in Survival Prediction of Metastatic Melanoma under PD-1 Inhibitors. Cancers, 13(5), 1019.
https://doi.org/10.3390/cancers13051019